Crossmark

The lung-protective effect of prior mRNA vaccination on breakthrough COVID-19 patients receiving high flow nasal oxygen for hypoxemic acute respiratory failure

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2022.07.003

Published Print: 2023-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Giraudo, C.

Guarnieri, G. http://orcid.org/0000-0003-3664-2024
Molena, B.

Caminati, M.

Stramare, R. http://orcid.org/0000-0002-1818-2290
Vianello, A. http://orcid.org/0000-0002-8790-6029
License Information

Text and Data Mining valid from 2023-09-01

Version of Record valid from 2022-07-15
More Information

This article is maintained by: Elsevier

Article Title: The lung-protective effect of prior mRNA vaccination on breakthrough COVID-19 patients receiving high flow nasal oxygen for hypoxemic acute respiratory failure

Journal Title: Pulmonology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pulmoe.2022.07.003

Content Type: simple-article

Copyright: © 2022 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below